Name | Number of supported studies | Average coverage | |
---|---|---|---|
glutamatergic neuron | 11 studies | 47% ± 17% | |
oligodendrocyte precursor cell | 11 studies | 37% ± 13% | |
GABAergic neuron | 8 studies | 46% ± 20% | |
interneuron | 6 studies | 35% ± 13% | |
neuron | 5 studies | 29% ± 12% | |
GABAergic interneuron | 3 studies | 45% ± 2% | |
retina horizontal cell | 3 studies | 23% ± 5% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 11 studies | 36% ± 19% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 75% | 361.13 | 1988 / 2642 | 60% | 2.09 | 423 / 705 |
ovary | 97% | 358.69 | 174 / 180 | 3% | 0.05 | 11 / 430 |
blood vessel | 84% | 330.18 | 1127 / 1335 | 0% | 0 | 0 / 0 |
uterus | 45% | 65.84 | 77 / 170 | 4% | 0.10 | 19 / 459 |
breast | 35% | 26.99 | 160 / 459 | 4% | 0.25 | 44 / 1118 |
thymus | 33% | 25.06 | 213 / 653 | 1% | 0.02 | 4 / 605 |
adrenal gland | 3% | 1.50 | 7 / 258 | 30% | 1.53 | 69 / 230 |
bladder | 29% | 24.24 | 6 / 21 | 1% | 0.02 | 5 / 504 |
lung | 18% | 10.58 | 105 / 578 | 1% | 0.01 | 6 / 1155 |
skin | 12% | 6.66 | 226 / 1809 | 0% | 0.00 | 2 / 472 |
prostate | 12% | 8.58 | 30 / 245 | 0% | 0.00 | 1 / 502 |
intestine | 11% | 14.49 | 103 / 966 | 0% | 0.01 | 2 / 527 |
esophagus | 2% | 1.31 | 32 / 1445 | 1% | 0.02 | 2 / 183 |
adipose | 2% | 1.22 | 30 / 1204 | 0% | 0 | 0 / 0 |
spleen | 1% | 0.49 | 3 / 241 | 0% | 0 | 0 / 0 |
kidney | 1% | 0.62 | 1 / 89 | 0% | 0.01 | 1 / 901 |
stomach | 1% | 0.28 | 2 / 359 | 0% | 0.01 | 1 / 286 |
pancreas | 0% | 0 | 0 / 328 | 1% | 0.01 | 1 / 178 |
heart | 0% | 0.14 | 3 / 861 | 0% | 0 | 0 / 0 |
muscle | 0% | 0.09 | 2 / 803 | 0% | 0 | 0 / 0 |
peripheral blood | 0% | 0.05 | 1 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
liver | 0% | 0 | 0 / 226 | 0% | 0 | 0 / 406 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 45 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0007156 | Biological process | homophilic cell adhesion via plasma membrane adhesion molecules |
GO_0007155 | Biological process | cell adhesion |
GO_0005886 | Cellular component | plasma membrane |
GO_0005509 | Molecular function | calcium ion binding |
Gene name | PCDH11X |
Protein name | Protocadherin-11 X-linked (Protocadherin-11) (Protocadherin on the X chromosome) (PCDH-X) (Protocadherin-S) |
Synonyms | KIAA1326 PCDH11 PCDHX |
Description | FUNCTION: Potential calcium-dependent cell-adhesion protein. |
Accessions | ENST00000373088.5 [Q9BZA7-5] Q9BZA7 ENST00000373097.5 [Q9BZA7-3] ENST00000406881.3 [Q9BZA7-8] ENST00000504220.6 [Q9BZA7-6] ENST00000682573.1 [Q9BZA7-1] ENST00000361655.6 [Q9BZA7-4] ENST00000373094.5 [Q9BZA7-1] |